These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
427 related items for PubMed ID: 26721005
1. RELATIONSHIP OF SERUM RESISTIN WITH INSULIN RESISTANCE AND OBESITY. Zaidi SI, Shirwany TA. J Ayub Med Coll Abbottabad; 2015; 27(3):552-5. PubMed ID: 26721005 [Abstract] [Full Text] [Related]
2. Serum resistin, adiposity and insulin resistance in Saudi women with type 2 diabetes mellitus. Al-Harithy RN, Al-Ghamdi S. Ann Saudi Med; 2005; 25(4):283-7. PubMed ID: 16212119 [Abstract] [Full Text] [Related]
3. [Association between both resistin, visfatin and insulin resistance as well as β cell function in the first-degree relatives of type 2 diabetes mellitus]. Zhang XJ, Wang Z, Li HH, Yu L, Gao S. Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1393-6. PubMed ID: 21223671 [Abstract] [Full Text] [Related]
4. Correlation of plasma resistin with obesity and insulin resistance in type 2 diabetic patients. Gharibeh MY, Al Tawallbeh GM, Abboud MM, Radaideh A, Alhader AA, Khabour OF. Diabetes Metab; 2010 Dec; 36(6 Pt 1):443-9. PubMed ID: 20739208 [Abstract] [Full Text] [Related]
5. [Serum resistin concentration and insulin resistance in obese children]. Liu GL, Fu XH, Jiang LH, Ma XC, Yang JY. Zhonghua Er Ke Za Zhi; 2006 Feb; 44(2):114-7. PubMed ID: 16624027 [Abstract] [Full Text] [Related]
6. Relationship between serum resistin concentration and proinflammatory cytokines in obese women with impaired and normal glucose tolerance. Janowska J, Zahorska-Markiewicz B, Olszanecka-Glinianowicz M. Metabolism; 2006 Nov; 55(11):1495-9. PubMed ID: 17046552 [Abstract] [Full Text] [Related]
7. Serum visfatin, resistin and IL-18 in A group of Egyptian obese diabetic and non diabetic individuals. Mabrouk R, Ghareeb H, Shehab A, Omar K, El-Kabarity RH, Soliman DA, Mohamed NA. Egypt J Immunol; 2013 Nov; 20(1):1-11. PubMed ID: 23888552 [Abstract] [Full Text] [Related]
8. Beneficial effects of liraglutide on adipocytokines, insulin sensitivity parameters and cardiovascular risk biomarkers in patients with Type 2 diabetes: a prospective study. Díaz-Soto G, de Luis DA, Conde-Vicente R, Izaola-Jauregui O, Ramos C, Romero E. Diabetes Res Clin Pract; 2014 Apr; 104(1):92-6. PubMed ID: 24530118 [Abstract] [Full Text] [Related]
9. Plasma resistin, insulin concentration in non-diabetic and diabetic, overweight/obese Thai. Chanchay S, Tungtrongchitr R, Harnroongroj T, Phonrat B, Rungseesakorn O, Paksanont S, Pooudong S, Saowakontha S, Varongchayakul C. Int J Vitam Nutr Res; 2006 May; 76(3):125-31. PubMed ID: 17048191 [Abstract] [Full Text] [Related]
10. [Reduced resistin levels in patients with type 2 diabetes mellitus]. Yang J, Li M, Wu CY, Wang H, Xu QS, Deng JY. Zhonghua Yi Xue Za Zhi; 2003 Sep 10; 83(17):1471-4. PubMed ID: 14521723 [Abstract] [Full Text] [Related]
11. Advanced oxidation protein products in obese women: its relation to insulin resistance and resistin. Koçak H, Oner-Iyidoğan Y, Gürdöl F, Oner P, Süzme R, Esin D, Işsever H. Clin Exp Med; 2007 Dec 10; 7(4):173-8. PubMed ID: 18188531 [Abstract] [Full Text] [Related]
12. Serum resistin positively correlates with serum lipids, but not with insulin resistance, in first-degree relatives of type-2 diabetes patients: an observational study in China. Niu XH, Li L, Li JY, Song Q, Jin MM, Liu JX. Medicine (Baltimore); 2017 Apr 10; 96(16):e6622. PubMed ID: 28422857 [Abstract] [Full Text] [Related]
13. Relevance and clinical significance of serum resistin level in obese T2DM rhesus monkey models. Qi SD, He ZL, Chen Y, Ma J, Yu WH, Li YY, Yang FM, Wang JB, Chen LX, Zhao Y, Lu SY. Exp Clin Endocrinol Diabetes; 2015 Sep 10; 123(8):508-13. PubMed ID: 26069076 [Abstract] [Full Text] [Related]
14. Correlation between serum resistin level and adiposity in obese individuals. Azuma K, Katsukawa F, Oguchi S, Murata M, Yamazaki H, Shimada A, Saruta T. Obes Res; 2003 Aug 10; 11(8):997-1001. PubMed ID: 12917505 [Abstract] [Full Text] [Related]
15. Serum resistin levels in Syrian obese patients with diabetes mellitus type II. Al-Sari IE, Al-Quobaili FA, Kabalan YM. Saudi Med J; 2007 Dec 10; 28(12):1890-4. PubMed ID: 18060223 [Abstract] [Full Text] [Related]
16. Ghrelin, resistin and insulin in obese diabetic women in Wad-Madani, Sudan. Elamin MA, Youseif SM, Mohammed HA. Afr Health Sci; 2020 Mar 10; 20(1):266-276. PubMed ID: 33402915 [Abstract] [Full Text] [Related]
17. Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome. Arikan S, Bahceci M, Tuzcu A, Kale E, Gökalp D. Gynecol Endocrinol; 2010 Mar 10; 26(3):161-6. PubMed ID: 20148738 [Abstract] [Full Text] [Related]
18. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL, Murphy LJ. Eur J Endocrinol; 2003 Oct 10; 149(4):331-5. PubMed ID: 14514348 [Abstract] [Full Text] [Related]
19. Roles of adipocyte derived hormone adiponectin and resistin in insulin resistance of type 2 diabetes. Lu HL, Wang HW, Wen Y, Zhang MX, Lin HH. World J Gastroenterol; 2006 Mar 21; 12(11):1747-51. PubMed ID: 16586545 [Abstract] [Full Text] [Related]
20. Serum resistin concentrations are higher in human obesity but independent from insulin resistance. Owecki M, Miczke A, Nikisch E, Pupek-Musialik D, Sowiński J. Exp Clin Endocrinol Diabetes; 2011 Feb 21; 119(2):117-21. PubMed ID: 20827661 [Abstract] [Full Text] [Related] Page: [Next] [New Search]